Welcome to Friday. Here are three things to keep an eye on during the trading day.Two of today’s three are animated by near-opposite human cravings, but both have been crucial drivers of this bull market: biotech stocks and REITs.Number 1:Biotechs are all about a hoped-for future, the promised huge payoff from smarts and risk-taking, magic molecules to extend lives and […]
BloombergThe iShares Nasdaq Biotechnology ETF over 12 months
Stocks are selling off on Thursday after a post-Fed rally yesterday.
But biotech stocks are rallying, up nearly 2%. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last week, Max Nisen at Quartz wrote that while everyone is focusing on massive tech valuations, the biotech industry is where things […]
View photo.(Bloomberg)The iShares Nasdaq Biotechnology ETF over 12 monthsStocks are selling off on Thursday after a post-Fed rally yesterday.
But biotech stocks are rallying, up nearly 2%. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last week, Max Nisen at Quartz wrote that while everyone is focusing on massive tech valuations, the biotech industry is where […]
View photo.(Bloomberg)The iShares Nasdaq Biotechnology ETF over 12 monthsStocks sold off on Thursday after a post-Fed rally on Wednesday.
But the Nasdaq still gained ground thanks to the biotech sector which gained about 2% on Thursday. In fact, biotech stocks have been on fire all year. They’re up about 15% year-to-date.Last month, Max Nisen at Quartz wrote that while everyone is focusing […]
* Energy shares lower on dollar strength, oversupply concern* Guess posts strong quarterly earnings, shares rally* Indexes: Dow off 0.6 pct, S&P off 0.5 pct, Nasdaq up 0.2 pct (Updates prices, changes comment, byline)By Rodrigo CamposNEW YORK, March 19 (Reuters) – U.S. stocks fell on Thursday as a stronger dollar weighed on oil and other commodity prices, with energy and […]
CORAL GABLES, FL / ACCESSWIRE / March 19, 2015 / BiotechStocks.com, an online destination for the burgeoning biotechnology sector focused on information concerning biotech stocks is proud to announce that after several months in development, the Company’s online destination has been fully optimized with live media and exclusive articles on biotech companies and biotech stocks.The biotech industry encompasses a wide […]
LONDON, March 19, 2015 /PRNewswire/ —Editor Note: For more information about this release, please scroll to bottom.Investor-Edge has initiated coverage on the following equities: Cytori Therapeutics Inc. (NASDAQ: CYTX), Oncolytics Biotech Inc. (NASDAQ: ONCY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Aeterna Zentaris Inc. (NASDAQ: AEZS), and Immunomedics Inc. (NASDAQ: IMMU). Free research report on Cytori Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Cytori%20Therapeutics&d=19-Mar-2015&s=CYTX. […]
View gallery.Biotech stocks have been breaking to new highs all over the market. Here are just a few:Esperion Therapeutics broke to a new high last week and skyrocketed Tuesday.
Ampio Pharmaceuticals bolted higher last week and touched a new high Wednesday.
Jazz Pharmaceuticals just hit a new high Wednesday as well.
The list goes on and on. Whether it is Receptos, NewLink Genetics, Biogen […]
LONDON, March 18, 2015 /PRNewswire/ —Editor Note: For more information about this release, please scroll to bottom.Investor-Edge has initiated coverage on the following equities: Orexigen Therapeutics Inc. (NASDAQ: OREX), Celgene Corporation (NASDAQ: CELG), PDL BioPharma Inc. (NASDAQ: PDLI), Amarin Corporation PLC (NASDAQ: AMRN), and Synergy Pharmaceuticals Inc. (NASDAQ: SGYP). Free research report on Orexigen Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Orexigen%20Therapeutics&d=18-Mar-2015&s=OREX. […]
The biotechnology story is one that continues to highlight evolving growth opportunities in the medical field. Whether you are a believer in the high valuations or not, these stocks have consistently posted double digit gains for more than half a decade and enthralled investors with their resiliency. That makes biotechnology companies worthy of consideration for those that are seeking high […]
